Video Experimental Relacionado
Updated: Feb 28, 2026
08:08
Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
14.7K
Gestión Basada en la Evidencia de la Hipertensión Pulmonar Persistente
1Children's Mercy Hospitals and Clinics, Kansas City, MO, USA carolrtrees@gmail.com.
Neonatal network : NN
|February 26, 2026
Resumen
El manejo de la hipertensión pulmonar persistente del recién nacido (HPPRN) es complejo. Los paquetes de intervención basados en la evidencia en las UCIN pueden mejorar la estabilización infantil y reducir las transferencias.
Área de la Ciencia:
- Medicina Neonatal
- Cardiología Pediátrica
- Cuidados Intensivos
Sus antecedentes:
- La hipertensión pulmonar persistente del recién nacido (HPPRN) implica una resistencia vascular pulmonar elevada y una transición de la circulación fetal alterada.
- El manejo de la HPPRN es un desafío debido a una fisiopatología compleja y multifactorial.
- La falta de consenso clínico y guías formales complica la atención de la HPPRN.
Objetivo del estudio:
- Proponer un enfoque integral y basado en la evidencia para el manejo de la HPPRN.
- Explorar los beneficios potenciales de los paquetes de intervención en UCIN de Nivel III.
Principales métodos:
- Revisión de la literatura existente sobre intervenciones para la HPPRN.
- Desarrollo de un paquete propuesto de intervenciones basadas en la evidencia.
- Enfoque en la aplicación dentro de las Unidades de Cuidados Intensivos Neonatales (UCIN) de Nivel III.
Principales resultados:
- Un enfoque integral es esencial para los neonatos críticamente enfermos con HPPRN.
- Los paquetes de intervención basados en la evidencia pueden mejorar la estabilización infantil.
- La implementación en UCIN de Nivel III podría disminuir potencialmente las transferencias a UCIN de Nivel IV.
Conclusiones:
- Un paquete estandarizado y basado en la evidencia de atención es crucial para el manejo de la HPPRN.
- La implementación de dichos paquetes puede mejorar los resultados de los neonatos de alto riesgo.
- Este enfoque podría optimizar la utilización de recursos en todos los niveles de UCIN.
Videos de Conceptos Relacionados
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
596
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
596
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
552
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
552
01:30Pulmonary Hypertension: Classification and Pathogenesis
721
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
721
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
680
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
680
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.4K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.4K